代谢组学在眼科中的研究进展

Abstract
Figure/Table
References (45)
Related Citation (15)

Download: PDF (629 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Metabonomics is a part of system biology. It is of great significance to explain gene function and to understand the overall view of life. It relies on nuclear magnetic resonance spectroscopy, mass spectrometry, chromatography, spectroscopy and other analytical chemistry techniques to obtain data. The examination specimens are usually plasma, urine, body fluid or tissue. It has been widely used in basic life science, clinical science, drug research and development, traditional Chinese medicine and other disciplines. The research in ophthalmology is also gradually increasing. This article reviews the basic principles of metabonomics and its achievements in dry eye, corneal diseases, crystal diseases, glaucoma, fundus diseases and optic nerve diseases.

Key words： Metabolomics Ophthalmology Mass spectrometers System biology

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Li LI Qingsong MIAO Wanhong

Cite this article:

ZHAO Li LI Qingsong MIAO Wanhong. Research progress of metabolomics in ophthalmology[J]. 中国医药导报, 2020, 17(5): 41-45.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2020/V17/I5/41

[1] Kitano H. Systems biology：a brief overview [J]. Science，2002，295（5560）：1662-1664.
[2] Fiehn O. Metabolomics—the link between genotypes and phenotypes [J]. Plant Mol Biol，2002，48（1-2）：155-171.
[3] Viant MR，Lyeth BG，Miller MG，et al. An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model [J]. NMR Biomed，2005，18（8）：507-516.
[4] Kunikata H，Ida T，Sato K，et al. Metabolomic profiling of reactive persulfides and polysulfides in the aqueous and vitreous humors [J]. Sci Rep，2017，7：41984.
[5] International Dry Eye Workshop （DEWS）. The definition and classification of dry eye disease：report of the Definition and Classification Subcommittee of the International Dry Eye Workshop [J]. Ocul Surf，2007，5：75-92.
[6] Murube J. Andrew de Roetth （1893-1981）：dacryologist who introduced the term dry eye [J]. Ocul Surf，2004，2：225-227.
[7] Perry HD. Dry eye disease：pathophysiology，classification，and diagnosis [J]. Am J Manag Care，2008，14：S79-S87.
[8] Moss SE，Klein R，Klein BE. Long-term incidence of dry eye in an older population [J]. Optom Vis Sci，2008，85：668-674.
[9] Chen L，Zhou L，Chan EC，et al. Characterization of the human tear metabolome by LC-MS/MS [J]. J Proteome Res，2011，10（10）：4876-4882.
[10] Galbis-Estrada C，Martinez-Castillo S，Morales JM，et al. Differential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopy [J]. Biomed Res Int，2014，2014：542549.
[11] Galbis-Estrada C，Pinazo-Durán MD，Martínez-Castillo S，et al. A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids [J]. Mol Vis，2015，21：555-567.
[12] Chen X，Rao J，Zheng Z，et al. Integrated tear proteome and metabolome reveal panels of inflammatory-related molecules via key regulatory pathways in dry eye syndrome [J]. J Proteome Res，2019，18（5）：2321-2330.
[13] Vehof J，Hysi PG，Hammond CJ，et al. A metabolome-wide study of dry eye disease reveals serum androgens as biomarkers [J]. Ophthalmology，2017，124（4）：505-511.
[14] Leppin K，Behrendt AK，Reichard M，et al. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea [J]. Invest Ophthalmol Vis Sci，2014，55（6）：3603-3615.
[15] Liu H，Sheng M，Liu Y，et al. Expression of SIRT1 and oxidative stress in diabetic dry eye [J]. Int J Clin Exp Pathol，2015，8（6）：7644-7653.
[16] Kieselbach GF. Diabetes：can severe vision disorders be prevented? [J]. Ther Umsch，1996，53（1）：68-73.
[17] Priyadarsini S，McKay TB，Sarker-Nag A，et al. Complete metabolome and lipidome analysis reveals novel biomarkers in the human diabetic corneal stroma [J]. Exp Eye Res，2016，153：90-100.
[18] Tsentalovich YP，Verkhovod TD，Yanshole VV，et al. Meta-bolomic composition of normal aged and cataractous human lenses [J]. Exp Eye Res，2015，134：15-23.
[19] Yanshole VV，Yanshole LV，Snytnikova OA. Quantitative metabolomic analysis of changes in the lens and aqueous humor under development of age-related nuclear cataract [J]. Metabolomics，2019，15（3）：29.
[20] Ji Y，Rong X，Lu Y. Metabolic characterization of human aqueous humor in the cataract progression after pars plana vitrectomy [J]. BMC Ophthalmol，2018，18（1）：63.
[21] Kang JH，Pasquale LR，Willett WC. Dietary fat consumption and primary open-angle glaucoma [J]. Am J Clin Nutr，2006，79：755-764.
[22] Quigley HA，Broman AT. The number of people with glaucoma worldwide in 2010 and 2020 [J]. Br J Ophthalmol，2004，90：262-267.
[23] Tham YC，Li X，Wong TY. Global prevalence of glaucoma and projections of glaucoma burden through 2040：a systematic review and meta-analysis [J]. Ophthalmology，2014，121：2081-2090.
[24] Yip JL，Foster PJ. Ethnic differences in primary angle-closure glaucoma [J]. Curr Opin Ophthalmol，2006，17：175-180.
[25] Rong S，Li Y，Guan Y，et al. Long-chain unsaturated fatty acids as possible important metabolites for primary angle-closure glaucoma based on targeted metabolomic analysis [J]. Biomed Chromatogr，2017，31（9）：e3963.
[26] Burgess LG，Uppal K，Walker DI，et al. Metabolome-Wide Association Study of primary open angle glaucoma [J]. Invest Ophthalmol Vis Sci，2015，56（8）：5020-5028.
[27] Buisset A，Gohier P，Leruez S，et al. Metabolomic profiling of aqueous humor in glaucoma points to taurine and spermine deficiency：findings from the eye-D study [J]. J Proteome Res，2019，18（3）：1307-1315.
[28] Hysi PG，Khawaja AP，Menni C，et al. Ascorbic acid metabolites are involved in intraocular pressure control in the general population [J]. Redox Biol，2019，20：349-353.
[29] Leruez S，Bresson T，Chao de la Barca JM，et al. A Plasma metabolomic signature of the exfoliation syndrome involves amino acids，acylcarnitines，and polyamines [J]. Invest Ophthalmol Vis Sci，2018，59（2）：1025-1032.
[30] Minhas G，Morishita R，Anand A. Preclinical models to investigate retinal ischemia：advances and drawbacks [J]. Front Neurol，2012，3：75.
[31] Osborne NN，Casson RJ，Wood JP，et al. Retinal ischemia：mechanisms of damage and potential therapeutic strategies [J]. Prog Retinal Eye Res，2004，23：91-147.
[32] D′Alessandro A，Cervia D，Catalani E，et al. Protective effects of the neuropeptides PACAP，substance P and the somatostatin analogue octreotide in retinal ischemia：a metabolomic analysis [J]. Mol Biosyst，2014，10（6）：1290-1304.
[33] Gottlieb F. Combined choroidal and retinal detachment [J]. Arch Ophthalmol，1972，88：481-486.
[34] Zhu J，Xu X，Zhang X. Surgical therapeutic results of rhegmatogenous retinal detachment associated with cho-roidal detachment [J]. Zhonghua Yan Ke Za Zhi，2002， 38：135-139.
[35] Li Z，Li Y，Huang X，et al. Quantitative analysis of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese using UBM [J]. Retina，2012，32：2020-2025.
[36] Yu M，Wu Z，Zhang Z，et al. Metabolomic analysis of human vitreous in rhegmatogenous retinal detachment associated with choroidal detachment [J]. Invest Ophthalmol Vis Sci，2015，56（9）：5706-5713.
[37] Balaratnasingam C，Freund KB，Tan AM，et al. Bullous variant of central serous chorioretinopathy：expansion of phenotypic features using multimethod imaging [J]. Ophthalmology，2016，123：1541-1552.
[38] Bondalapati S，Pathengay A，Chhablani J. External drainage for exudative retinal detachment secondary to central serous chorioretinopathy [J]. Eye Sci，2015，30：204-208.
[39] Kowalczuk L，Matet A，Dor M，et al. Proteome and metabolome of subretinal fluid in central serous chorioretinopathy and rhegmatogenous retinal detachment：a pilot case study [J]. Transl Vis Sci Technol，2018，7（1）：3.
[40] Friedman DS，O′Colmain BJ，Munoz B，et al. Prevalence of age-related macular degeneration in the United States [J]. Arch Ophthalmol，2004，122：564-572.
[41] Laíns I，Kelly RS，Miller JB，et al. Human plasma meta-bolomics study across all stages of age-related macular degeneration identifies potential lipid biomarkers [J]. Ophthalmology，2018，125（2）：245-254.
[42] Laíns I，Duarte D，Barros AS，et al. Urine Nuclear Magnetic Resonance （NMR） metabolomics in age-related macular degeneration [J]. J Proteome Res，2019，18（3）：1278-1288.
[43] Osborn MP，Park Y，Parks MB，et al. Metabolome-wide association study of neovascular age-related macular degeneration [J]. PLoS One，2013，27（8）：72737.
[44] Bocca C，Kouassi Nzoughet J，et al. A plasma metabolomic signature involving purine metabolism in human optic atrophy 1 （OPA1）-related disorders [J]. Invest Ophthalmol Vis Sci，2018，59（1）：185-195.
[45] Chao de la Barca JM，Simard G，Amati-Bonneau P，et al. The metabolomic signature of Leber′s hereditary optic neuropathy reveals endoplasmic reticulum stress [J]. Brain，2016，139（11）：2864-2876.